ecancer

Treatment of melanoma in Latin America

Dr Alessandro Testori - European Institute of Oncology, Milan, Italy

9 Jul 2013

Vemurafenib and ipilimumab for metastatic melanoma

Dr Caroline Robert - Institute Gustave Roussy, Paris, France

14 Jun 2013

Role of microenvironment and stroma in cancer therapy

Dr Stephen Ansell - Mayo Clinic, Rochester, USA

7 Jun 2013

Science behind phase I clinical trials: targeting tumour cell development pathways

Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA

6 Jun 2013

ASCO 2013 highlights

Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA

6 Jun 2013

Phase I study measures effect of ipilimumab and nivolumab combination in melanoma patients

Prof Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA

3 Jun 2013

Nivolumab with peptide vaccine in patients naive to or that failed ipilimumab

Dr Jeffrey Weber - Moffitt Cancer Center, Tampa, USA

3 Jun 2013

Nivolumab blocking PD1 in lung cancer and melanoma

Dr Suzanne Topalian - Johns Hopkins Medical Center, Baltimore, USA

3 Jun 2013

Selumetinib, the first effective drug for advanced melanoma of the eye

Dr Richard Carvajal - Memorial Sloan Kettering Cancer Center, New York, USA

3 Jun 2013

Ipilimumab and BRAF inhibitors for advanced melanoma

Dr Lynn Schuchter - University of Pennsylvania, USA

2 Jun 2013

PDL1 inhibitors in melanoma

Dr Roy Herbst - Yale Cancer Center, New Haven, USA

2 Jun 2013

Comment on drug developments in advanced melanoma

Dr Roy Herbst - Yale Cancer Center, New Haven, USA

2 Jun 2013

More from ecancer